BCRX Smart Money
BioCryst Pharmaceuticals, Inc.
1W: +2.0%
1M: -4.4%
3M: -15.0%
YTD: +8.0%
1Y: +12.5%
3Y: +37.8%
5Y: -46.1%
$8.10
+0.22 (+2.79%)
Weekly Expected Move ±5.3%
$7
$7
$8
$8
$8
Credit Risk of going bust: lower than 54% of companies Debt: 16.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.15 (down 98%), BioCryst Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $409.9M against a stock market value of $2.07B.
Distance to default 5.48 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $197.7M (short-term plus half of long-term), stock volatility 47.5%; Altman Z'' -13.51. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.15 (down 98%), BioCryst Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $409.9M against a stock market value of $2.07B.
Distance to default 5.48 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $197.7M (short-term plus half of long-term), stock volatility 47.5%; Altman Z'' -13.51. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026359
Institutions Holding
+15 vs prior
127.2%
Ownership
+12.79%
58
New
132
Increased
125
Reduced
37
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Milne Jill C. | director | A-Grant/Award | 1,288 | $9.70 | $12K | Filing |
| 2026-08-31 | MILANO VINCENT | director | A-Grant/Award | 1,159 | $9.70 | $11K | Filing |
| 2026-08-31 | McKee Amy E | director | A-Grant/Award | 644 | $9.70 | $6K | Filing |
| 2026-08-31 | Frank Steven | director | A-Grant/Award | 1,288 | $9.70 | $12K | Filing |
| 2026-08-31 | Stonehouse Jon P | director | A-Grant/Award | 644 | $9.70 | $6K | Filing |
| 2026-06-11 | Stonehouse Jon P | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | HEGGIE THERESA | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | Frank Steven | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | Milne Jill C. | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | Galson Steven K | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | LEVIN ALAN G | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | SANDERS MACHELLE | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | MILANO VINCENT | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-06-11 | McKee Amy E | director | A-Grant/Award | 15,294 | $— | $0 | Filing |
| 2026-05-29 | MILANO VINCENT | director | A-Grant/Award | 1,122 | $8.91 | $10K | Filing |
| 2026-05-29 | McKee Amy E | director | A-Grant/Award | 631 | $8.91 | $6K | Filing |
| 2026-05-29 | Stonehouse Jon P | director | A-Grant/Award | 631 | $8.91 | $6K | Filing |
| 2026-05-29 | Frank Steven | director | A-Grant/Award | 1,262 | $8.91 | $11K | Filing |
| 2026-05-29 | Milne Jill C. | director | A-Grant/Award | 1,262 | $8.91 | $11K | Filing |
| 2026-05-18 | McKee Amy E | director | S-Sale | 11,180 | $8.97 | $100K | Filing |
| 2026-05-13 | Barnes Alane P | officer: chief legal officer | S-Sale | 62,500 | $9.54 | $596K | Filing |
| 2026-04-06 | Menon Sandeep | officer: chief r&d officer | A-Grant/Award | 205,150 | $— | $0 | Filing |
| 2026-03-16 | Barnes Alane P | officer: chief legal officer | S-Sale | 150,000 | $9.15 | $1.4M | Filing |
| 2026-03-02 | Stonehouse Jon P | director | D-Sale to Issuer | 305,995 | $8.64 | $2.6M | Filing |
| 2026-02-27 | McKee Amy E | director | A-Grant/Award | 642 | $8.75 | $6K | Filing |
🏛️ Congressional Trades
9 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2026-07-10 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-07-10 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2026-07-09 | Gilbert Ray Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-11-13 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-11-13 | Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2025-11-12 | Gilbert Ray Cisneros | House | Buy | $1,001 - $15,000 | Filing |
| 2023-10-16 | Josh Gottheimer | House | Buy | $1,001 - $15,000 | Filing |
| 2023-09-15 | Josh Gottheimer | House | Sell | $1,001 - $15,000 | Filing |
| 2022-08-11 | Josh Gottheimer | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 23,893,036 | $239M | +1,242,048 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 15,827,186 | $158M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 15,191,098 | $152M | +2,982,738 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 15,096,403 | $151M | +58,403 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 11,364,236 | $114M | +228,474 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11,139,158 | $111M | -105,467 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 11,020,968 | $110M | — | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 10,308,888 | $103M | +2,874,855 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 9,540,764 | $95M | +9,540,764 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 8,300,000 | $83M | +1,275,000 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 6,775,349 | $68M | +382,721 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 6,248,046 | $62M | +465,270 | 2026-06-30 | Filing |
| Aberdeen Group plc | 5,310,871 | $53M | +270,201 | 2026-06-30 | Filing |
| UBS Group AG | 5,078,280 | $51M | +134,286 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 4,801,284 | $48M | -290,481 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 4,481,874 | $45M | +2,134,431 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 4,009,240 | $40M | — | 2026-06-30 | Filing |
| Nuveen, LLC | 4,007,237 | $40M | +187,974 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 3,394,729 | $34M | +3,207,008 | 2026-06-30 | Filing |
| GW&K Investment Management, LLC | 3,171,113 | $32M | -69,349 | 2026-06-30 | Filing |